Total
0
Shares
Wellness and Beauty Solutions (ASX:WNB) - CEO, Christine Parkes
CEO, Christine Parkes
Source: Professional Beauty
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Wellness and Beauty Solutions’ (WNB) is set to ramp up sales of its anti-bacterial product MICRO19 to increase its cashflow during the last quarter of the financial year after entering into a joint venture (JV)
  • WNB signed an agreement with Piggott Investments and Glegra to form the JV company, MICRO 19, last month
  • The JV is producing $0.5 million worth of MICRO19 orders, which will be recognised in the final quarter, with more expected from domestic and international retailers
  • WNB reported lower cash receipts in the third quarter, as a result of the retail sector being hit by the recent bushfire and current COVID-19 crisis
  • However, the company managed to reduce cash outflow by more than 11 per cent, despite lower sales
  • WNB finished on Friday in the grey, with shares trading for 1.1 cents each

Wellness and Beauty Solutions (WNB) is ramping up its joint venture product MICRO19, to increase its cashflow into next quarter.

WNB signed an agreement with Piggott Investments and Glegra to form the JV company, MICRO 19, last month. The company is producing half a million dollars worth of its anti-bacterial MICRO19 product which will be recognised in the final quarter, with more expected from domestic and international retailers.

WNB today released its quarterly update, the third for the 2020 financial year, and reported lower cash receipts as a result of the recent bushfire crisis and current COVID-19 pandemic.

Despite lower third-quarter sales figures of just over $3 million, down from $3.8 million, WNB slashed its cash outflow by more than 11 per cent. This came after the company trimmed costs across product manufacturing and operating, staff, administration and corporate expenditure.

The company reports it has less than $300,000 cash in hand to start the final quarter, however, there are finance facilities available in excess of $3 million to WNB if MICRO19 sales don’t take off as quickly as they’d hoped.

New chairman, Julian Glynn, has been installed with the tasks of guiding WNB through their uncertain future and ensuring maximum profits are gained from the MICRO19 JV.

If the latest announcement is anything to go by, Mr Glynn is well on track to deliver, particularly if sales take off.

WNB finished on Friday in the grey, with shares trading for 1.1 cents each.

WNB by the numbers
More From The Market Herald
The Market Herald Video

" Wellfully (ASX:WFL) raises $5m to develop products further

Wellfully (WFL) has raised $5 million of firm commitments through an oversubscribed placement.
Keytone Dairy (ASX:KTD) - CEO, Danny Rotman

" Keytone Dairy (ASX:KTD) ushers in $15m in revenue

Keytone Dairy (KTD) has ushered in $15 million worth of revenue over the September quarter, its second quarter of
The Market Herald Video

" Experience (ASX:EXP) secures $51m and launches $4M retail raise

Experience Co (EXP) is funding the acquisition of outdoor adventure company, Trees Adventure, thanks to a completed $51 million institutional entitlement offer, with a retail offer
Nutritional Growth Solutions (ASX:NGS) - CEO and Managing Director, Liron Fendell

" Nutritional Growth Solutions (ASX:NGS) partners with Ultrahealth

Nutritional Growth Solutions (NGS) is accelerating its distribution in China via an agreement with an Australian-based distributor, Ultrahealth Group.